Revista nº 815

Tratamiento y prevención de COVID-19 | Casas-Maldonado, F 48 Actual Med.2022;107(815):39- 50 CONFLICTO DE INTERESES El autor/a de este artículo declara no tener ningún tipo de conflicto de intereses respecto a lo expuesto en el presente trabajo. REFERENCIAS BIBLIOGRÁFICAS 1. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneu- monia associated with the 2019 novel coronavirus in- dicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523. DOI: 10.1016/S0140-6736(20)30154-9 2. Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumo- nia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. DOI: 10.1056/NEJMoa2001316 3. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-In- fected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. DOI: 10.1001/jama.2020.1585 4. Gandhi M, Yokoe DS, Havlir DV. Asymptomatic Trans- mission, the Achilles’ Heel of Current Strategies to Con- trol Covid-19. N Engl J Med. 2020 May 28;382(22):2158- 2160. DOI: 10.1056/NEJMe2009758 5. World Health Organization. Coronavirus Disease 2019 (COVID-19): Situation Report-51. https://apps.who. int/iris/bitstream/handle/10665/331475/ nCoVsitrep- 11Mar2020-eng. pdf?sequence=1&isAllowed=y 6. WHO Coronavirus (COVID-19) Dashboard. Disponible en: https://covid19.who.int/ 7. Spain situation COVID19. Disponible en: https://co- vid19.who.int/region/euro/country/es 8. World Health Organization (WHO). Novel coronavirus (2019-nCoV) situation report – 38, 27 February 2020. WHO Bulletin; 2020 [consultado 25 Jul 2020]. Disponi- ble en: https://www.who.int/emergencies/diseases/no- vel-coronavirus-2019/situation-reports 9. Real Decreto 463/2020, de 14 de marzo, por el que se declara el estado de alarma para la gestión de la situa- ción de crisis sanitaria ocasionada por el COVID-19. BOE núm. 67, de 14 de Mar de 2020; p. 25390-400 [con- sultado 25 Jul 2020]. Disponible en: https://www.boe. es/eli/es/rd/2020/03/14/463 10. Banco de España. Escenarios macroeconómicos de re- ferencia para la economía española tras el COVID-19. Boletín Económico 2/2020 [consultado 25 Jul 2020]. Disponible en: https://www.bde.es/f/webbde/GAP/Sec- ciones/SalaPrensa/COVID-19/be2002-art1.pdf 11. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of co- ronavirus disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. DOI: 10.1056/NEJMoa2002032 12. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 2020 Apr 7;323(13):1239- 1242. DOI: 10.1001/jama.2020.2648 13. Cevik M, Tate M, Lloyd O, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe. 2021 Jan;2(1):e13-e22. DOI: 10.1016/S2666-5247(20)30029-X 14. Leisman DE, Ronner L, Pinotti R, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic re- view, meta-analysis, and comparison with other inflam- matory syndromes. Lancet Respir Med 2020; 8:1233– 1244. DOI: 10.1016/S2213-2600(20)30103-X 15. McElvaney OJ, McEvoy NL, McElvaney OF, et al. Charac- terization of the inflammatory response to severe CO- VID-19 illness. Am J Respir Crit Care Med 2020; 202: 812–821. DOI: 10.1164/rccm.202005-1583OC 16. Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications [Inter- net]. [citado 14 de enero de 2021]. Disponible en: ht- tps://www.ons.gov.uk/news/statementsandletters/ prevalenceoflongcovidsymptomsandcovid19complica- tions 17. Ministerio de Sanidad. Centro de Coordinación de Aler- tas y Emergencias Sanitarias. Información clínica CO- VID-19. Actualización, 25 de marzo 2021- https://www. mscbs.gob.es/profesionales/saludPublica/ccayes/ alertasActual/nCov/documentos/Documento_CLINICA. pdf 18. Kucirka LM, Lauer SA, Laeyendecker O, et al. Varia- tion in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Ann Intern Med. 2020 Aug 18;173(4):262-267. DOI: 10.7326/M20-1495 19. Raptis CA, Hammer MM, Short RG, et al., Chest CT. and Coronavirus Disease (COVID-19): A Critical Review of the Literature to Date. AJR Am J Roentgenol. 2020 Oct;215(4):839-842. DOI: 10.2214/AJR.20.23202 20. Martínez Chamorro E, Díez Tascón A, Ibáñez Sanz L, Os- saba Vélez S, Borruel Nacenta S. Radiologic diagnosis of patients with COVID-19. Radiologia (Engl Ed). 2021 Jan-Feb;63(1):56-73. English, Spanish. DOI: 10.1016/j. rx.2020.11.001 21. Ojha V, Mani A, Pandey NN, et al. CT in coronavirus di- sease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients. Eur Radiol. 2020 Nov;30(11):6129-6138. DOI: 10.1007/s00330-020- 06975-7